Literature DB >> 23482375

A novel two-hit rodent model of postoperative acute lung injury: priming the immune system leads to an exaggerated injury after pneumonectomy.

Robert G Evans1, Oscar B A Ndunge, Babu Naidu.   

Abstract

OBJECTIVES: Postoperative acute lung injury (PALI) is a rare, poorly understood, usually fatal condition, accounting for the majority of deaths following lung resection. Its low frequency and unpredictable development make the identification of the mechanisms of injury from clinical studies alone almost impossible. Multiple validated 'two-hit models' exist for ALI secondary to other causes. We describe a novel rodent 'two-hit' model of PALI: a low-grade immune stimulus, such as sepsis, greatly aggravates the injury in the remaining lung observed following pneumonectomy.
METHODS: Under general anaesthesia, rats received either low-dose intratracheal lipopolysaccharide (IT-LPS) challenge (10 μg for 1 h) followed by left posterolateral thoracotomy, one-lung ventilation (OLV), pneumonectomy and 3 h of ventilation; 500 μl IT 0.9% saline followed by the same surgery or IT-LPS followed by sham surgery and ventilation. All other conditions were constant. Lung injury is heralded by neutrophil accumulation, which was determined by right lung bronchoalveolar lavage cell count. Data are presented as mean ± standard error of the mean. The T-test was used to compare normally distributed groups with correction for multiple comparisons.
RESULTS: A dose-response curve identified the clinically relevant 'low dose' of LPS to be used in further studies. Ventilatory parameters were standardized to reflect clinical practice (volume-control, tidal volume of 6 ml/kg, positive end-expiratory pressure of 2 cmH2O, maximum airway pressure of <15 cmH2O). There was a degree of adaptation to obtain a consistent and robust model with retest validity. OLV and pneumonectomy alone produced a small lung injury (65.1 ± 5), as did 10 µg intratracheal LPS alone (50.7 ± 6.9). However, when OLV, pneumonectomy and 10 µg LPS were combined, an exaggerated injury occurred (161.4 ± 10.3), P = 0.007.
CONCLUSIONS: Early results show that a two-hit model of PALI is viable and that sepsis aggravates the response to pneumonectomy. The model is now being further characterized. Once established, this model will offer the chance to better understand PALI and to develop and test novel therapies and risk reduction strategies for the condition.

Entities:  

Keywords:  Acute respiratory distress syndrome; Lobectomy; Lung resection; Pneumonectomy; Postoperative acute lung injury; Surgical model

Mesh:

Substances:

Year:  2013        PMID: 23482375      PMCID: PMC3653484          DOI: 10.1093/icvts/ivt077

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  17 in total

Review 1.  Does a conservative fluid management strategy in the perioperative management of lung resection patients reduce the risk of acute lung injury?

Authors:  Robert G Evans; Babu Naidu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-05-22

Review 2.  The pathogenesis of lung injury following pulmonary resection.

Authors:  S Jordan; J A Mitchell; G J Quinlan; P Goldstraw; T W Evans
Journal:  Eur Respir J       Date:  2000-04       Impact factor: 16.671

3.  Endogenous interleukin-4 and interleukin-10 regulate experimental lung ischemia reperfusion injury.

Authors:  Alexander S Farivar; Baiya Krishnadasan; Babu V Naidu; Steven M Woolley; Edward D Verrier; Michael S Mulligan
Journal:  Ann Thorac Surg       Date:  2003-07       Impact factor: 4.330

4.  The role of proinflammatory cytokines in lung ischemia-reperfusion injury.

Authors:  Baiya Krishnadasan; Babu V Naidu; Karen Byrne; Charles Fraga; Edward D Verrier; Michael S Mulligan
Journal:  J Thorac Cardiovasc Surg       Date:  2003-02       Impact factor: 5.209

5.  Postpneumonectomy pulmonary edema.

Authors:  R A Zeldin; D Normandin; D Landtwing; R M Peters
Journal:  J Thorac Cardiovasc Surg       Date:  1984-03       Impact factor: 5.209

6.  Surfactant protein a inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein.

Authors:  Cordula Stamme; Mareike Müller; Lutz Hamann; Thomas Gutsmann; Ulrich Seydel
Journal:  Am J Respir Cell Mol Biol       Date:  2002-09       Impact factor: 6.914

7.  Critical role of reactive nitrogen species in lung ischemia-reperfusion injury.

Authors:  Babu V Naidu; Charles Fraga; Andrew L Salzman; Csaba Szabo; Edward D Verrier; Michael S Mulligan
Journal:  J Heart Lung Transplant       Date:  2003-07       Impact factor: 10.247

8.  A model of pulmonary atelectasis in rats: activation of alveolar macrophage and cytokine release.

Authors:  J M Kisala; A Ayala; R N Stephan; I H Chaudry
Journal:  Am J Physiol       Date:  1993-03

9.  Treatment of hypoxemia during one-lung ventilation using intravenous almitrine.

Authors:  Nicolas Dalibon; Marc Moutafis; Ngai Liu; Jean-Dominique Law-Koune; Stéphanie Monsel; Marc Fischler
Journal:  Anesth Analg       Date:  2004-03       Impact factor: 5.108

10.  Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery.

Authors:  Marc Licker; John Diaper; Yann Villiger; Anastase Spiliopoulos; Virginie Licker; John Robert; Jean-Marie Tschopp
Journal:  Crit Care       Date:  2009-03-24       Impact factor: 9.097

View more
  2 in total

1.  Sleeve lobectomy compared with pneumonectomy for operable centrally located non-small cell lung cancer: a meta-analysis.

Authors:  Zhengjun Li; Wei Chen; Mozhu Xia; Hongxu Liu; Yongyu Liu; Ilhan Inci; Fabio Davoli; Ryuichi Waseda; Pier Luigi Filosso; Abby White
Journal:  Transl Lung Cancer Res       Date:  2019-12

Review 2.  Potential effects of medicinal plants and secondary metabolites on acute lung injury.

Authors:  Daniely Cornélio Favarin; Jhony Robison de Oliveira; Carlo Jose Freire de Oliveira; Alexandre de Paula Rogerio
Journal:  Biomed Res Int       Date:  2013-10-09       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.